scholarly journals Establishment of an iPSC line (JSPHi001-A) from a patient with familial dilated cardiomyopathy and atrial fibrillation caused by LMNA missense mutation (c.1003C > T)

2021 ◽  
Vol 53 ◽  
pp. 102349
Author(s):  
Yike Zhang ◽  
Yue Zhu ◽  
Yongping Lin ◽  
Hailei Liu ◽  
Hongwu Chen ◽  
...  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Kensuke Ihara ◽  
Tetsuo Sasano ◽  
Yuichi Hiraoka ◽  
Marina Togo-Ohno ◽  
Yurie Soejima ◽  
...  

Abstract Dilated cardiomyopathy (DCM) is a fatal heart disease characterized by left ventricular dilatation and cardiac dysfunction. Recent genetic studies on DCM have identified causative mutations in over 60 genes, including RBM20, which encodes a regulator of heart-specific splicing. DCM patients with RBM20 mutations have been reported to present with more severe cardiac phenotypes, including impaired cardiac function, atrial fibrillation (AF), and ventricular arrhythmias leading to sudden cardiac death, compared to those with mutations in the other genes. An RSRSP stretch of RBM20, a hotspot of missense mutations found in patients with idiopathic DCM, functions as a crucial part of its nuclear localization signals. However, the relationship between mutations in the RSRSP stretch and cardiac phenotypes has never been assessed in an animal model. Here, we show that Rbm20 mutant mice harboring a missense mutation S637A in the RSRSP stretch, mimicking that in a DCM patient, demonstrated severe cardiac dysfunction and spontaneous AF and ventricular arrhythmias mimicking the clinical state in patients. In contrast, Rbm20 mutant mice with frame-shifting deletion demonstrated less severe phenotypes, although loss of RBM20-dependent alternative splicing was indistinguishable. RBM20S637A protein cannot be localized to the nuclear speckles, but accumulated in cytoplasmic, perinuclear granule-like structures in cardiomyocytes, which might contribute to the more severe cardiac phenotypes.


2008 ◽  
Vol 102 (11) ◽  
pp. 1426-1432 ◽  
Author(s):  
Lin Zhang ◽  
Aihua Hu ◽  
Haixin Yuan ◽  
Liang Cui ◽  
Guobin Miao ◽  
...  

Author(s):  
P Hutsteiner ◽  
N Jenewein ◽  
J Christ ◽  
O Ortmann ◽  
U Germer

Circulation ◽  
1995 ◽  
Vol 92 (12) ◽  
pp. 3387-3389 ◽  
Author(s):  
Jean-Bernard Durand ◽  
Linda L. Bachinski ◽  
Lisa C. Bieling ◽  
Grazyna Z. Czernuszewicz ◽  
Antoine B. Abchee ◽  
...  

2021 ◽  
Vol 11 (3) ◽  
pp. 122-128
Author(s):  
Priya Bhardwaj ◽  
Christoffer Rasmus Vissing ◽  
Niels Kjær Stampe ◽  
Kasper Rossing ◽  
Alex Hørby Christensen ◽  
...  

Background: AARS2 encodes the mitochondrial protein alanyl-tRNA synthetase 2 (MT-AlaRS), an important enzyme in oxidative phosphorylation. Variants in AARS2 have previously been associated with infantile cardiomyopathy. Case summary: A 4-year-old girl died of infantile-onset dilated cardiomyopathy (DCM) in 1996. Fifteen years later, her 21-year-old brother was diagnosed with DCM and ultimately underwent heart transplantation. Initial sequencing of 15 genes discovered no pathogenic variants in the brother at the time of his diagnosis. However, 9 years later re-screening in an updated screening panel of 129 genes identified a homozygous AARS2 (c.1774C > T) variant. Sanger sequencing of the deceased girl confirmed her to be homozygous for the AARS2 variant, while both parents and a third sibling were all found to be unaffected heterozygous carriers of the AARS2 variant. Discussion: This report underlines the importance of repeated and extended genetic screening of elusive families with suspected hereditary cardiomyopathies, as our knowledge of disease-causing mutations continuously grows. Although identification of the genetic etiology in the reported family would not have changed the clinical management, the genetic finding allows genetic counselling and holds substantial value in identifying at-risk relatives.


Sign in / Sign up

Export Citation Format

Share Document